Zimmer Biomet
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,824,200 | $1,942,000 | $1,889,200 | $1,940,100 |
Gross Profit | 1,285,600 | 1,178,600 | 1,169,400 | 1,401,300 |
EBITDA | 532,500 | 645,300 | 631,100 | 701,000 |
EBIT | 281,600 | 402,100 | 392,500 | 459,800 |
Net Income | 249,200 | 242,800 | 172,400 | 419,200 |
Net Change In Cash | 1,824,200 | 1,942,000 | 1,889,200 | 1,940,100 |
Free Cash Flow | 368,600 | 264,000 | 78,400 | 446,700 |
Cash | 569,000 | 420,100 | 393,000 | 415,800 |
Basic Shares | 203,000 | 206,400 | 206,200 | 208,600 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,394,200 | $6,939,900 | $6,827,300 | $7,024,500 |
Gross Profit | 5,310,400 | 4,920,400 | 4,866,900 | 4,896,200 |
EBITDA | 2,448,900 | 2,212,600 | 2,160,100 | 969,700 |
EBIT | 1,497,200 | 1,286,200 | 1,222,400 | -63,000 |
Net Income | 1,024,000 | 231,400 | 401,600 | -137,400 |
Net Change In Cash | 7,394,200 | 6,939,900 | 6,827,300 | 7,024,500 |
Cost of Revenue | 58,500 | -310,400 | 168,900 | |
Free Cash Flow | 892,400 | 1,096,800 | 1,347,200 | 1,086,600 |
Cash | 415,800 | 375,700 | 378,100 | 802,100 |
Basic Shares | 209,700 | 210,300 | 210,400 | 207,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $1.74 |
2024-06-30 | $2.01 |
2024-03-31 | $1.94 |
2023-12-31 | $2.20 |
